Clinical Trial Update: A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia [Phase 2]

View source ↗

Summary

A Phase 2 long-term extension study of ORX750 for Narcolepsy Type 1, Narcolepsy Type 2, and Idiopathic Hypersomnia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia
• Narcolepsy Type

Drugs mentioned

• ORX750

Snippet

Sponsor: Centessa Pharmaceuticals (UK) Limited | Conditions: Narcolepsy Type 1, Narcolepsy Type 2 | Phase 2 | Status: RECRUITING